Published in J Palliat Med on December 01, 2003
Factors influencing death at home in terminally ill patients with cancer: systematic review. BMJ (2006) 5.71
Continuity of outpatient and inpatient care by primary care physicians for hospitalized older adults. JAMA (2009) 1.90
Associations between home death and GP involvement in palliative cancer care. Br J Gen Pract (2009) 1.84
Continuity of care and intensive care unit use at the end of life. Arch Intern Med (2009) 1.70
Can primary care visits reduce hospital utilization among Medicare beneficiaries at the end of life? J Gen Intern Med (2008) 1.47
A population-based study of age inequalities in access to palliative care among cancer patients. Med Care (2008) 1.35
Why do patients with cancer access out-of-hours primary care? A retrospective study. Br J Gen Pract (2014) 1.09
Emergency calls and need for emergency care in patients looked after by a palliative care team: Retrospective interview study with bereaved relatives. BMC Palliat Care (2008) 0.94
Palliative care patients in the emergency department. J Palliat Care (2008) 0.91
Health care restructuring and family physician care for those who died of cancer. BMC Fam Pract (2005) 0.90
Involvement of general practitioners in palliative cancer care: a qualitative study. Support Care Cancer (2013) 0.85
A GP Caregiver Needs Toolkit versus usual care in the management of the needs of caregivers of patients with advanced cancer: a randomized controlled trial. Trials (2010) 0.83
Advanced lung cancer patients' experience with continuity of care and supportive care needs. Support Care Cancer (2012) 0.82
Escalation of oncologic services at the end of life among patients with gynecologic cancer at an urban, public hospital. J Oncol Pract (2015) 0.79
End-of-life care from the perspective of primary care providers. J Gen Intern Med (2012) 0.77
End-of-life planning with frail patients attending general practice: an exploratory prospective cross-sectional study. Br J Gen Pract (2016) 0.75
Predictors of Place of Death of Individuals in a Home-Based Primary and Palliative Care Program. J Am Geriatr Soc (2016) 0.75
Provider continuity prior to the diagnosis of advanced lung cancer and end-of-life care. PLoS One (2013) 0.75
Family physician continuity of care and emergency department use in end-of-life cancer care. Med Care (2003) 2.46
Trends in the place of death of cancer patients, 1992-1997. CMAJ (2003) 2.18
Towards using administrative databases to measure population-based indicators of quality of end-of-life care: testing the methodology. Palliat Med (2006) 1.60
Validation of instruments to evaluate primary healthcare from the patient perspective: overview of the method. Healthc Policy (2011) 1.51
Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor. J Pharmacol Exp Ther (2006) 1.41
Transitions in care during the end of life: changes experienced following enrolment in a comprehensive palliative care program. BMC Palliat Care (2005) 1.17
Family practice/Primary health care nurses in Nova Scotia. Can Nurse (2007) 1.15
Toward population-based indicators of quality end-of-life care: testing stakeholder agreement. Cancer (2008) 1.14
Home visits by family physicians during the end-of-life: Does patient income or residence play a role? BMC Palliat Care (2005) 0.98
Preventive medication use among persons with limited life expectancy. Prog Palliat Care (2011) 0.96
Evidence-based cardiovascular care in the community: a population-based cross-sectional study. BMC Fam Pract (2004) 0.95
Which patients receive advice on diet and exercise? Do certain characteristics affect whether they receive such advice? Can Fam Physician (2008) 0.93
Drug management for hypertension in type 2 diabetes in family practice. Can Fam Physician (2009) 0.92
Health care restructuring and family physician care for those who died of cancer. BMC Fam Pract (2005) 0.90
The effect of an educational intervention on meperidine use in Nova Scotia, Canada: a time series analysis. Pharmacoepidemiol Drug Saf (2011) 0.89
Adoption of open-access scheduling in an academic family practice. Can Fam Physician (2010) 0.88
Upholding the principles of primary care in preceptors' practices. Fam Med (2002) 0.83
Impact of comorbidity and healthcare utilization on colorectal cancer stage at diagnosis: literature review. Cancer Causes Control (2011) 0.82
Where a cancer patient dies: the effect of rural residency. J Rural Health (2005) 0.82
Spiritual and emotional support of primary informal end-of-life caregivers in Nova Scotia. J Palliat Care (2012) 0.81
Determining cell number during cell culture using the Scepter cell counter. J Vis Exp (2010) 0.80
Hypertension and type 2 diabetes: what family physicians can do to improve control of blood pressure--an observational study. BMC Fam Pract (2011) 0.79
Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors. Bioorg Med Chem Lett (2008) 0.78
Assessing the feasibility of extracting clinical information to create quality indicators from primary healthcare practice EMRs. Healthc Q (2013) 0.77
Inequity in access to guideline-recommended colorectal cancer treatment in Nova Scotia, Canada. Healthc Policy (2012) 0.77
Distribution and sharing of palliative care costs in rural areas of Canada. J Palliat Care (2014) 0.76
Potential for drug interactions in seniors with osteoarthritis. Can Fam Physician (2006) 0.76
Use of opioid analgesics among older persons with colorectal cancer in two health districts with palliative care programs. J Pain Symptom Manage (2012) 0.75
Assessing the acceptability of quality indicators and linkages to payment in primary care in nova scotia. Healthc Policy (2011) 0.75
Understanding the challenges to improve transition to palliative care: An issue for the primary malignant brain tumour population. Can J Neurosci Nurs (2016) 0.75
Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors. Bioorg Med Chem Lett (2010) 0.75
Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors. Bioorg Med Chem Lett (2008) 0.75